spironolactone has been researched along with cholecalciferol in 4 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (50.00) | 24.3611 |
| 2020's | 2 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
| Cai, Y; Jia, LX; Qi, YF; Tang, CS; Wang, X; Wu, SY; Xiao, CS; Yu, YR | 1 |
| Biyashev, D; Dalal, P; Demczuk, M; Evans, S; Lu, KQ; Onay, UV; Techner, JM | 1 |
| Alesutan, I; Auer, T; Buehling, SS; Degenhart, G; Feger, M; Grebe, S; Hammer, F; Hauser, T; Krane, V; Lang, F; Malzahn, U; Masyout, J; Pasch, A; Tuffaha, R; Voelkl, J; Wanner, C | 1 |
1 trial(s) available for spironolactone and cholecalciferol
| Article | Year |
|---|---|
Protective effects of spironolactone on vascular calcification in chronic kidney disease.
Topics: Aldosterone; Alkaline Phosphatase; Animals; Aorta; Biomarkers; Cholecalciferol; Core Binding Factor Alpha 1 Subunit; Female; Gene Expression; Humans; Kidney; Mice; Mice, Inbred DBA; Mineralocorticoid Receptor Antagonists; Myocytes, Smooth Muscle; Nephrectomy; Primary Cell Culture; Prospective Studies; Receptors, Mineralocorticoid; Renal Dialysis; Renal Insufficiency, Chronic; Spironolactone; Transcription Factor Pit-1; Vascular Calcification | 2021 |
3 other study(ies) available for spironolactone and cholecalciferol
| Article | Year |
|---|---|
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
Endogenous aldosterone is involved in vascular calcification in rat.
Topics: Aldosterone; Alkaline Phosphatase; Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Animals; Aorta; Calcium; Captopril; Cholecalciferol; Collagen; Fibrosis; Hypertension; Male; Mineralocorticoid Receptor Antagonists; Nicotine; Osteopontin; Rats; Rats, Sprague-Dawley; RNA, Messenger; Spironolactone; Vascular Calcification | 2012 |
A novel treatment for skin repair using a combination of spironolactone and vitamin D3.
Topics: Animals; Apoptosis; Cholecalciferol; Female; Gene Expression Regulation; Macrophages; Mechlorethamine; Mice; RAW 264.7 Cells; Skin; Spironolactone; Wound Healing; Wounds and Injuries | 2020 |